Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00296244 · ClinicalTrials.gov registry record · Phase 4

Steroid Free Immunosuppression in Liver Transplantation

A Phase 4 study of Liver Cirrhosis and Liver Transplant Disorder, sponsored by Thomas Jefferson University.

Completed
Registry status
Phase 4
Development phase
40
Enrollment target
1
Study location

NCT00296244 is a Phase 4 study of Liver Cirrhosis and Liver Transplant Disorder that has completed, run by Thomas Jefferson University. The registered enrollment target is 40 participants, below the 1,002-participant average among 15 other Liver Cirrhosis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00296244, a Phase 4 study of Liver Cirrhosis and Liver Transplant Disorder, has completed, sponsored by Thomas Jefferson University.

COMPLETED
Registry status
Phase 4
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether steroid-related complications can be avoided by using steroid-free immuno-suppressive drug regimen after liver transplantation.

Conditions Studied

Liver Cirrhosis Liver Transplant Disorder

Interventions

  • DRUG Tacrolimus
  • DRUG Steroids
  • DRUG Basiliximab
  • DRUG Enteric-coated Mycophenolic acid (EC-MPA)

Study Locations (1)

Pennsylvania

  • Thomas Jefferson University - Philadelphia

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2006-02
Est. Completion 2008-06
Phase Phase 4

Sponsor

Thomas Jefferson University

292 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00296244

The ClinicalTrials.gov registry entry for NCT00296244 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,002-participant average among 15 other Liver Cirrhosis trials with a reported enrollment target (96% lower). The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Liver Cirrhosis appearing as the primary indexed condition, and to 4 interventions - of which Tacrolimus is the first listed.

NCT00296244 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00296244 about?

NCT00296244 is a clinical study titled "Steroid Free Immunosuppression in Liver Transplantation". The purpose of this study is to determine whether steroid-related complications can be avoided by using steroid-free immuno-suppressive drug regimen after liver transplantation.

What is the current status of trial NCT00296244?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2006-02. Estimated completion is 2008-06.

What conditions does trial NCT00296244 study?

This clinical trial studies the following conditions: Liver Cirrhosis, Liver Transplant Disorder.

What interventions are being tested in trial NCT00296244?

The interventions under investigation include: Tacrolimus (DRUG), Steroids (DRUG), Basiliximab (DRUG), Enteric-coated Mycophenolic acid (EC-MPA) (DRUG).

Who is sponsoring clinical trial NCT00296244?

This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00296244 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Liver Cirrhosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Liver Cirrhosis

All registered trials for this condition

Liver Transplant Disorder

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.